The Third Annual
An invitation-only forum for global leaders shaping health-related cannabis policy worldwide, alongside patients, healthcare professionals, researchers and responsible industry leaders. The 2027 theme is Markets in Practice.
About the 2027 Event
The 2027 Global Cannabis Regulatory Summit (“GCRS” or the “Summit”) brings together an international community of regulators, policymakers, healthcare professionals, researchers, patients and patient advocates, standards organisations and responsible industry leaders to address the practical challenges shaping cannabis regulation and market development around the world.
Now in its third year, the Summit will build on the dialogue and relationships established in Washington, D.C. in 2025 and London in 2026, bringing the community together in Zürich to share experience, examine common challenges and identify areas where greater international coordination can support safe, responsible and sustainable market development.
The 2027 Summit comes at an important moment. As more countries move from policy development to market implementation, attention is shifting from legislative reform to the practical work of making regulatory frameworks function effectively in practice. Under the 2027 theme, Markets in Practice, the programme is organised around the Summit’s core pillars of Standards and Responsibility, with collaboration running throughout and building on the priorities and next steps identified in the 2026 White Paper.
Monday 5 April
Welcome reception, evening
Tuesday 6 April
Symposium day one + Networking dinner
Wednesday 7 April
Symposium day two
The Host City
Zürich sits at the centre of European policy, science and finance, in a country with one of the most progressive, holistic approaches to health-related cannabis regulation, and is easily reached from across the region.
What to Expect
Candid discussions with senior regulators, government officials, healthcare leaders, patients and patient advocates, standards organisations, researchers and responsible industry leaders, including sessions open to regulators only. Designed as a trusted forum, not a traditional conference.
Panels and workshops examine how health-related cannabis regulation is working across jurisdictions, from licensing and product quality to patient access, market oversight and international trade.
Perspectives and recommendations from the Summit inform future White Papers and support the launch of the Global Advocacy Hub, strengthening collaboration among regulators worldwide and ensuring progress extends beyond the event itself.
Invited Participants to Include
Senior representatives from regulatory agencies, health ministries, medicines authorities, standards organisations and legislative bodies. The 2026 Summit brought together representatives from 30 countries, including Albania, Australia, Barbados, Belgium, Brazil, Canada, Colombia, Czechia, Denmark, France, Germany, Ghana, Iceland, Israel, Italy, Jamaica, Japan, Lebanon, the Netherlands, New Zealand, North Macedonia, Poland, Saint Lucia, Saint Vincent and the Grenadines, Spain, Sri Lanka, Switzerland, Ukraine, the United Kingdom and the United States.
A curated group of executives, physicians, pharmacists, researchers, patients and patient advocates, standards experts and industry leaders committed to advancing responsible health-related cannabis markets. GCRS is designed to foster dialogue between regulators and the organisations responsible for implementing, researching and operating within evolving regulatory frameworks.
2027 Global Cannabis Regulatory Summit
